Study S002431

COOrdinating CaRDIology CliNics RAndomized Trial of Interventions to Improve OutcomEs (COORDINATE) - Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol (PDF)Statistical Analysis Plan (PDF)

Registration

Registration: NCT03936660
Acronym: COORDINATE
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: COMPLETED
Enrollment: 1049
Start: 2019-07-25
Primary completion: 2022-12-30
Lead sponsor: Duke University
Conditions: Diabetes Mellitus, Type 2; Cardiovascular Diseases
Interventions: OTHER:Intense Education Intervention
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Number of Participants Prescribed All 3 Groups of Recommended Evidence-based Medications [Up to 12 Months]

Linked records (5)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0050905	Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial Christopher Bull Granger, Carolina Digital Repository (University of North Carolina at Chapel Hill)	2025	Randomized trial	DOI	cites ClinicalTrials.gov:NCT03936660
R0009916	Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial. Tannu M, Circulation	2024	Randomized trial	PMID 38934111 DOI	cites ClinicalTrials.gov:NCT03936660; registry reference DERIVED:38934111
R0011239	Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial. Pagidipati NJ, JAMA	2023	Randomized trial	PMID 36877177 DOI	cites ClinicalTrials.gov:NCT03936660; registry reference DERIVED:36877177
R0012285	Novel Diabetes Drugs and the Cardiovascular Specialist. Sattar N, Journal of the American College of Cardiology	2017	Narrative review	PMID 28545639 DOI	registry reference BACKGROUND:28545639
R0022060	Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. Marso SP, The New England journal of medicine	2016	Randomized trial	PMID 27295427 DOI	registry reference BACKGROUND:27295427